CRISPR Therapeutics: Audience

CRISPR Therapeutics is dedicated to developing transformative medicines utilizing its proprietary CRISPR/Cas9 gene-editing technology. The company focuses on creating innovative therapies for serious diseases, including sickle cell disease and beta thalassemia.